🇺🇸 FDA
Patent

US 7582312

Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof

granted A61KA61K38/00A61K9/0082

Quick answer

US patent 7582312 (Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof) held by Discovery Laboratories, Inc. expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Discovery Laboratories, Inc.
Grant date
Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K38/00, A61K9/0082, A61K9/19, A61P